A detailed history of Manufacturers Life Insurance Company, The transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 42,992 shares of PTCT stock, worth $1.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,992
Previous 43,796 1.84%
Holding current value
$1.99 Million
Previous $1.34 Million 19.12%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$30.39 - $37.66 $24,433 - $30,278
-804 Reduced 1.84%
42,992 $1.6 Million
Q2 2024

Aug 14, 2024

BUY
$24.69 - $40.12 $65,675 - $106,719
2,660 Added 6.47%
43,796 $1.34 Million
Q1 2024

May 14, 2024

SELL
$24.15 - $31.95 $592,109 - $783,350
-24,518 Reduced 37.34%
41,136 $1.2 Million
Q4 2023

Feb 13, 2024

SELL
$18.07 - $29.37 $2,945 - $4,787
-163 Reduced 0.25%
65,654 $1.81 Million
Q3 2023

Nov 15, 2023

SELL
$22.41 - $41.99 $353,809 - $662,938
-15,788 Reduced 19.35%
65,817 $1.47 Million
Q2 2023

Aug 11, 2023

BUY
$40.4 - $59.1 $1.4 Million - $2.05 Million
34,615 Added 73.66%
81,605 $3.32 Million
Q1 2023

May 15, 2023

BUY
$38.16 - $48.86 $381,638 - $488,648
10,001 Added 21.28%
56,991 $2.76 Million
Q4 2022

Aug 11, 2023

SELL
$33.53 - $54.79 $118,997 - $194,449
-3,549 Reduced 7.02%
46,990 $1.79 Million
Q4 2022

Feb 13, 2023

SELL
$33.53 - $54.79 $118,997 - $194,449
-3,549 Reduced 7.02%
46,990 $1.79 Million
Q3 2022

Aug 11, 2023

SELL
$41.85 - $53.85 $20,799 - $26,763
-497 Reduced 0.97%
50,539 $2.54 Million
Q3 2022

Nov 03, 2022

SELL
$41.85 - $53.85 $20,799 - $26,763
-497 Reduced 0.97%
50,539 $2.54 Million
Q2 2022

Aug 11, 2023

SELL
$25.6 - $45.23 $11,136 - $19,675
-435 Reduced 0.85%
51,036 $2.04 Million
Q2 2022

Aug 15, 2022

SELL
$25.6 - $45.23 $11,136 - $19,675
-435 Reduced 0.85%
51,036 $2.05 Million
Q1 2022

Aug 11, 2023

SELL
$33.33 - $44.6 $183,981 - $246,192
-5,520 Reduced 9.69%
51,471 $1.92 Million
Q1 2022

May 20, 2022

BUY
$33.33 - $44.6 $532,246 - $712,217
15,969 Added 44.98%
51,471 $1.92 Million
Q4 2021

Feb 16, 2022

SELL
$35.36 - $41.86 $6,859 - $8,120
-194 Reduced 0.54%
35,502 $1.42 Million
Q3 2021

Nov 12, 2021

SELL
$37.01 - $44.74 $125,056 - $151,176
-3,379 Reduced 8.65%
35,696 $1.33 Million
Q2 2021

Aug 12, 2021

BUY
$37.95 - $49.37 $160,262 - $208,489
4,223 Added 12.12%
39,075 $1.65 Million
Q1 2021

May 03, 2021

SELL
$46.8 - $68.92 $99,543 - $146,592
-2,127 Reduced 5.75%
34,852 $1.65 Million
Q4 2020

Feb 12, 2021

BUY
$47.96 - $67.64 $62,300 - $87,864
1,299 Added 3.64%
36,979 $2.26 Million
Q3 2020

Nov 09, 2020

SELL
$45.41 - $57.07 $46,726 - $58,725
-1,029 Reduced 2.8%
35,680 $1.67 Million
Q2 2020

Aug 10, 2020

SELL
$42.56 - $54.98 $64,691 - $83,569
-1,520 Reduced 3.98%
36,709 $1.86 Million
Q1 2020

May 15, 2020

BUY
$32.37 - $59.36 $126,016 - $231,088
3,893 Added 11.34%
38,229 $1.71 Million
Q4 2019

Feb 14, 2020

SELL
$32.22 - $50.07 $33,927 - $52,723
-1,053 Reduced 2.98%
34,336 $1.65 Million
Q3 2019

Nov 12, 2019

BUY
$33.82 - $48.17 $5,647 - $8,044
167 Added 0.47%
35,389 $1.23 Million
Q2 2019

Aug 14, 2019

BUY
$35.42 - $45.0 $64,216 - $81,585
1,813 Added 5.43%
35,222 $1.59 Million
Q1 2019

May 13, 2019

BUY
$28.09 - $39.49 $152,135 - $213,877
5,416 Added 19.35%
33,409 $1.26 Million
Q4 2018

Feb 14, 2019

SELL
$29.83 - $46.51 $42,865 - $66,834
-1,437 Reduced 4.88%
27,993 $961,000
Q3 2018

Nov 14, 2018

SELL
$33.9 - $47.77 $135,972 - $191,605
-4,011 Reduced 11.99%
29,430 $1.38 Million
Q2 2018

Aug 14, 2018

BUY
$25.7 - $47.88 $89,307 - $166,383
3,475 Added 11.6%
33,441 $1.13 Million
Q1 2018

May 15, 2018

SELL
$17.46 - $32.59 $16,447 - $30,699
-942 Reduced 3.05%
29,966 $811,000
Q4 2017

Feb 08, 2018

BUY
$15.14 - $20.89 $545 - $752
36 Added 0.12%
30,908 $516,000
Q3 2017

Nov 14, 2017

BUY
$16.81 - $21.61 $518,958 - $667,143
30,872
30,872 $618,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.31B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.